EDGAR Filing Documents for 0001193125-10-036435

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-10-036435

Filing Date

2010-02-22

Accepted

2010-02-22 16:44:19

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d20f.htm	20-F	2126561
2	SUBSIDIARIES OF THE REGISTRANT	dex8.htm	EX-8	18019
3	CONSENT OF KESSELMAN & KESSELMAN	dex10.htm	EX-10	2627
4	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	dex12i.htm	EX-12.(I)	9600
5	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	dex12ii.htm	EX-12.(II)	9587
6	CERTIFICATION OF THE CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	dex13.htm	EX-13	4859
	Complete submission text file	0001193125-10-036435.txt		5095768

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	teva-20091231.xml	EX-101.INS	844762
8	XBRL TAXONOMY EXTENSION SCHEMA	teva-20091231.xsd	EX-101.SCH	19935
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	teva-20091231_cal.xml	EX-101.CAL	53131
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	teva-20091231_def.xml	EX-101.DEF	124895
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	teva-20091231_lab.xml	EX-101.LAB	127898
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	teva-20091231_pre.xml	EX-101.PRE	155523

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)